Evidence map›Paper›PMID 20511368›Full record

ArticleThe Journal of antimicrobial chemotherapy2010

A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.

Yajun Song, Philippe Roumagnac, François-Xavier Weill, John Wain, Christiane Dolecek, Camila J Mazzoni, Kathryn E Holt, Mark Achtman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevalence of Antimicrobial Resistance Genes inTropical medicine and infectious disease · 2022
    Review
  4. Article
  5. Carrion's Disease: the Sound of Silence.Clinical microbiology reviews · 2018
    Review
  6. Article
  7. Article
  8. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Characterization of non-classical quinolone resistance inBiomolecular detection and quantification · 2014
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Yajun SongEnvironmental Research Institute, University College Cork, Lee Road, Cork, Ireland.
Philippe Roumagnac
François-Xavier Weill
John Wain
Christiane Dolecek
Camila J Mazzoni
Kathryn E Holt
Mark Achtman
University College Cork · IECharité - Universitätsmedizin Berlin · DEHospital for Tropical Diseases · VNInstitut Pasteur · FRPublic Health England · GBWellcome Sanger Institute · GB

Funding

Medical Research Council G0600805Wellcome Trust
6 · The paper itself

Abstract

objectivesDecreased susceptibility to fluoroquinolones has become a major problem for the successful therapy of human infections caused by Salmonella enterica, especially the life-threatening typhoid and paratyphoid fevers.

methodsBy using Luminex xTAG beads, we developed a rapid, reliable and cost-effective multiplexed genotyping assay for simultaneously detecting 11 mutations in gyrA, gyrB and parE of S. enterica serovars Typhi and Paratyphi A that result in nalidixic acid resistance (Nal(R)) and/or decreased susceptibility to fluoroquinolones.

resultsThis assay yielded unambiguous single nucleotide polymorphism calls on extracted DNA from 292 isolates of Salmonella Typhi (Nal(R) = 223 and Nal(S) = 69) and 106 isolates of Salmonella Paratyphi A (Nal(R) = 24 and Nal(S) = 82). All of the 247 Nal(R) Salmonella Typhi and Salmonella Paratyphi A isolates were found to harbour at least one of the target mutations, with GyrA Phe-83 as the most common one (143/223 for Salmonella Typhi and 18/24 for Salmonella Paratyphi A). We also identified three GyrB mutations in eight Nal(S) Salmonella Typhi isolates (six for GyrB Phe-464, one for GyrB Leu-465 and one for GyrB Asp-466), and mutations GyrB Phe-464 and GyrB Asp-466 seem to be related to the decreased ciprofloxacin susceptibility phenotype in Salmonella Typhi. This assay can also be used directly on boiled single colonies.

conclusionsThe assay presented here would be useful for clinical and reference laboratories to rapidly screen quinolone-resistant isolates of Salmonella Typhi and Salmonella Paratyphi A, and decipher the underlying genetic changes for epidemiological purposes.

Indexed as

Polymorphism, Single NucleotideAnti-Bacterial AgentsDNA, BacterialDNA GyraseDNA Topoisomerase IVFluoroquinolonesGenotypeHumansMicrobial Sensitivity TestsMutation, MissenseSalmonella paratyphi ASalmonella typhiAnti-Bacterial AgentsDNA, BacterialDNA GyraseDNA Topoisomerase IVFluoroquinolones

Identifiers

PMID20511368
PMCPMC2904664
OpenAlexW2134036472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.